Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine

[1]  A. Hoischen,et al.  Progressive multifocal leukoencephalopathy in an immunocompetent patient , 2016, Annals of clinical and translational neurology.

[2]  H. Hirsch,et al.  Treatment of progressive multifocal leukoencephalopathy with interleukin 7. , 2014, JAMA neurology.

[3]  Markus Moll,et al.  IVIg Immune Reconstitution Treatment Alleviates the State of Persistent Immune Activation and Suppressed CD4 T Cell Counts in CVID , 2013, PloS one.

[4]  Hans H Hirsch,et al.  The human JC polyomavirus (JCPyV): virological background and clinical implications , 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[5]  D. Clifford,et al.  A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes , 2013, Journal of Neurovirology.

[6]  G. d’Ettorre,et al.  HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity , 2013, Journal of NeuroVirology.

[7]  L. Nencioni,et al.  New Insights on Human Polyomavirus JC and Pathogenesis of Progressive Multifocal Leukoencephalopathy , 2013, Clinical & developmental immunology.

[8]  J. Berciano,et al.  Progressive multifocal leukoencephalopathy and idiopathic CD4 lymphocytopenia , 2013, Journal of the Neurological Sciences.

[9]  D. Taylor,et al.  Progressive Multifocal Leukoencephalopathy in a Heart Transplant Recipient Following Rituximab Therapy for Antibody‐Mediated Rejection , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  Allen J Aksamit,et al.  Progressive multifocal leukoencephalopathy , 2008, Continuum.

[11]  K. Warnatz,et al.  Common variable immunodeficiency - an update , 2012, Arthritis Research & Therapy.

[12]  J. Berger,et al.  Update on Progressive Multifocal Leukoencephalopathy , 2012, Current Neurology and Neuroscience Reports.

[13]  H. Günthard,et al.  Progressive multi-focal leukoencephalopathy as a rare lethal complication in untreated sarcoidosis , 2012, BMJ Case Reports.

[14]  R. Moenster,et al.  Mirtazapine and mefloquine therapy for progressive multifocal leukoencephalopathy in a patient infected with human immunodeficiency virus. , 2012, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[15]  I. Koralnik,et al.  Frequent Infection of Cortical Neurons by JC Virus in Patients With Progressive Multifocal Leukoencephalopathy , 2012, Journal of neuropathology and experimental neurology.

[16]  T. Yamawaki,et al.  Akinetic mutism caused by HIV-associated progressive multifocal leukoencephalopathy was successfully treated with mefloquine: a serial multimodal MRI Study. , 2012, Internal medicine.

[17]  M. Kawamoto,et al.  Mefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. , 2012, Internal medicine.

[18]  L. Ngo,et al.  Role of CD4+ and CD8+ T-Cell Responses against JC Virus in the Outcome of Patients with Progressive Multifocal Leukoencephalopathy (PML) and PML with Immune Reconstitution Inflammatory Syndrome , 2011, Journal of Virology.

[19]  R. Gold,et al.  Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis. , 2010, Archives of neurology.

[20]  R. Eleopra,et al.  Progressive multifocal leukoencephalopathy in a patient with Good's syndrome. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[21]  É. Oksenhendler,et al.  Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  D. Clifford,et al.  Determinants of survival in progressive multifocal leukoencephalopathy , 2009, Neurology.

[23]  K. Simon,et al.  Identification and Characterization of Mefloquine Efficacy against JC Virus In Vitro , 2009, Antimicrobial Agents and Chemotherapy.

[24]  J. McArthur,et al.  Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy. , 2009, Archives of neurology.

[25]  C. Cunningham-Rundles,et al.  Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. , 2007, The Journal of infectious diseases.

[26]  J. Bogousslavsky,et al.  Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[27]  A. De Luca,et al.  Reduced Rate of Diagnostic Positive Detection of JC Virus DNA in Cerebrospinal Fluid in Cases of Suspected Progressive Multifocal Leukoencephalopathy in the Era of Potent Antiretroviral Therapy , 2005, Journal of Clinical Microbiology.

[28]  B. Roth,et al.  The Human Polyomavirus, JCV, Uses Serotonin Receptors to Infect Cells , 2004, Science.

[29]  Kimatha Oxford Grice,et al.  Adult norms for a commercially available Nine Hole Peg Test for finger dexterity. , 2003, The American journal of occupational therapy : official publication of the American Occupational Therapy Association.

[30]  V. Mathiowetz,et al.  Adult norms for the Box and Block Test of manual dexterity. , 1985, The American journal of occupational therapy : official publication of the American Occupational Therapy Association.

[31]  U. Bucher,et al.  [Familial autoimmune hemolytic animia (AIHA) with negative Coombs test, lymphocytopenia and hypogammaglobulinemia]. , 1975, Schweizerische medizinische Wochenschrift.